Keto-enol tautomerism of hydroxynaphthoquinoneoxime ligands: Copper complexes and topoisomerase inhibition activity
Graphical abstract
Introduction
Topoisomerases (TOPO) are DNA enzymes that play an essential role in cellular processes like DNA replication, transcription, chromosome condensation, and most importantly, in the mitosis to decatenate the daughter chromosomes. During DNA replication and transcription processes, a large number of positive and negative supercoils are formed ahead of the replication. These supercoils lead to stalling replication machinery [1] wherein the TOPO enzyme fine-tunes and modulates the topology of DNA supercoiling and helps them relax to facilitate protein interactions to further replication [2]. Therefore, these enzymes are considered magicians of the DNA world to solve topological problems of DNA [1]. Based on their activity, these DNA cleaving enzymes are classified into two types [2] types I (TOPO I) that cleave only one of the strands and relax the DNA through the strand passage mechanism, and type II(TOPO II) that cleaves both the strands and do the same by swivel mechanism. These enzymes are subdivided into type IA and type IB based on protein attachment to the phosphate (5′ and 3′) and type IIA and type IIB on the structural considerations [3].
Several antitumor drugs inhibit the DNA function by either directly binding to the DNA (intercalating agents or groove binding agents) or indirectly inhibiting the function of DNA enzymes like TOPO [4]. Some compounds act directly on the DNA and damage it by modifying or cleaving the same, altering the cell's biochemical activities [5]. Understanding TOPO's role in many disease conditions, researchers studied and characterized these enzymes using topoisomerase inhibitors (TOPO-In) in different experiments. TOPO-In can also be classified as catalytic inhibitors and TOPO poisons. TOPO poisons act on the drug stabilized cleavable complexes to the extreme level that cells can no longer tolerate [6]. Catalytic inhibitors interact with the TOPO and do not bind to the DNA by inhibiting the enzyme activity. TOPO poisons act differently where these molecules bind to the TOPO only after the DNA is cleaved by TOPO to stabilize these cleaved complexes and lead to cell death [7].
Tumor cells are highly proliferative, and elevated TOPO expression is reported in these cells compared to normal cells [8]. Therefore, drugs that can bind and damage DNA have been developed and have an excellent chemotherapy scope. Camptothecin (CPT) and etoposide (VP-16) act as TOPO poisons to the TOPO I and TOPO II family. Despite several TOPO-In being available in size, potency, and selectivity, several parameters can be optimized. To date, the TOPO-In developed has a polycyclic scaffold as its preferred structure that can bind to the catalytic site of DNA and enzyme interface. Such chemical structures are not feasible to synthesize and make the molecule very rigid; moreover, their cellular uptake is too low.
On the other hand, metal ions are potent and can cleave DNA but are very non-selective. Few studies also show metal complexes as potential inhibitors of TOPO [9,10]. However, some reports suggest increasing TOPO inhibition activity upon complexation with copper ion [11,12]. A strategy would be to develop smaller scaffold structures with functional groups that can complex with a metal and form homo-oligomers, showing synergistic activity upon cellular uptake. Therefore, in the present work, a panel of small molecules was synthesized that were complexed with copper.
Several nonmetallic synthetic topoisomerase inhibitors were proposed in recent years, including benzoxanthone derivatives, acridines, trisubstituted pyridines, and thiosemicarbazones benzophenanthridines, nitrofurans, purine analogs, anilinothiazoloquinolines, etc. [13]. Metal complexes of Cu(II) [14], [15], [16] Ru(II) [17], [18], [19], [20], [21], [22], Pt(II) [23], Pd(II) [24], Au(III) [25], Mn(II) [26], Zn(II) [27,28] and Ru(III) [18] are also known as topoisomerase inhibitors; however, their studies are scarce as compared to nonmetallic synthetic topoisomerase inhibitors. Osimertinib, a third generation inhibitor used in lung cancer treatment. Multilayer films are prepared by Xu et al. for controlled release of drug release [29], [30], [31].
An enormous number of naphthoquinones exhibit cytotoxic and anticancer activity towards a large number of cancer cell lines. It has been proved that naphthoquinone possesses anticancer activity through inhibition of the topoisomerase-II enzyme [32,33]. The compounds containing quinone scaffold as topoisomerase inhibitors include HU331, Cpd-9 naphthothiophenedione, TU100 naphthoquinone, and natural molecules products α-lapachone, eleutherin, SH-7, plumbagin, and clinically used include doxorubicin mitoxantrone. To the best of our knowledge, there is only one report in the literature of quinone metal complex as a topoisomerase II inhibitor [34]. This investigation targets naphthoquinoneoxime-based Cu(II) complexes as topoisomerase inhibitors. Copper complexes of the deprotonated ligands 3‑hydroxy-4-(hydroxylamine)naphthalene-1(4H)-one; 1(Cu-1; [Cu(1)2], Cu-2; (Py+)[Cu(1)2]), 3‑hydroxy-4-(hydroxylamine)−2-methylnaphthalen-1(4H)-one; 2 (Cu-3; [Cu(2)2], Cu-4; (Py+)2[Cu4(2)8], 2‑chloro-3‑hydroxy-4-(hydroxylamine)naphthalene-1(4H)-one; 3 (Cu-5; [Cu(3)2], Cu-6; [Cu(3)2](Py) are synthesized and characterized. Complex Cu-4, a tetramer, is crystallized in triclinic space group P-1. Coordination of ligand 2 in this complex is as ‘keto’ and ‘enol’ tautomeric forms. Hence the existence of tautomeric forms of the ligands 1 to 3 in polar solvents are extensively studied by NMR spectroscopy, and 1H, 13C, gDQCOSY, gHSQCAD methods are used to assign the proton and carbon chemical shift of tautomers in this investigation.
Moreover, tautomers are separated by preparative HPLC. Time-dependent NMR experiments in CD3OD-d4 solvent monitored their tautomer interconversion of the isolated tautomers. Anticancer activity of Cu-1 to Cu-6 complexes has been evaluated against cancer cell lines THP 1 and COLO205. The potential topoisomerase II inhibitor activity, DNA cleavage activity of the ligands 1, 2, and 3, their precursors of all copper(II) complexes were evaluated.
Section snippets
Materials
All the chemicals used in synthesizing oxime ligands and metal complexes are of analytical grade. 2-hydroxynaphthalene-1,4‑dione, 2-methylnaphthalene-1,4‑dione and 2,3-dichloronaphthalene-1,4‑dione, CuClO4. 6H2O obtained from Sigma-Aldrich. HPLC grade dimethylsulfoxide (DMSO), hydroxylamine hydrochloride, AR grade methanol, diethyl ether, sodium carbonate (Na2CO3), potassium hydroxide (KOH), hydrogen peroxide(H2O2), conc. HCl, conc. H2SO4 and H2O2 were obtained from Qualigen chemicals. Dry
Result and discussion
The starting materials used to synthesize the oxime ligands, viz., 2-hydroxynaphthalene-1,4‑dione (a) for ligand 1, are commercially available; however, precursors for ligand 2; 2‑hydroxy-3-methylnaphthalene-1,4‑dione (d) was synthesized [36] by using vitamin K3, 2-methylnaphthalene-1,4‑dione (a). For ligand 3 the precursor used is 2‑chloro-3-hydroxynaphthalene-1,4‑dione (e) was used, it was synthesized from 2,3-dichloronaphthalene-1,4‑dione (b), adapting the literature reported procedure [37].
Conclusions
Cu(II) complexes of 2‑hydroxy-(3R)−1,4-naphthoquinone-1-oxime ligands (R = H (1); in Cu-1 and Cu-2, R= -CH3 (2); in Cu-3 and Cu-4 and R = –Cl (3); in Cu-5 and Cu-6) are discussed in this investigation. Various techniques like elemental analysis, FT-IR, single-crystal X-ray diffraction studies have performed the characterization of complexes. The ligands 1, 2, and 3 exist in ‘ortho’ and ‘para’ tautomeric form in CD3OD-d4 solution; NMR experiments revealed this. Time-dependent NMR experiments
CRediT authorship contribution statement
Yogesh Shinde: Conceptualization, Methodology, Data curation, Writing – original draft. Rishikesh Patil: Conceptualization, Methodology, Data curation, Writing – original draft. V. Badireenath Konkimalla: Conceptualization, Writing – review & editing, Data curation, Supervision, Funding acquisition. Siva Bharath Merugu: Methodology, Data curation. Vivek Mokashi: Methodology, Data curation. Shital Harihar: Methodology, Data curation. Jérome Marrot: Methodology, Data curation. Ray J. Butcher:
Declaration of Competing Interest
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Acknowledgement
SSG is grateful to DST-SERB, the Government of India, for financial support (Ref. No. EMR/2016/007912). VBK and SBM are thankful to National Institute of Science Education and Research (NISER), Bhubaneswar, India, for the funding and research facilities.
References (80)
- et al.
A comprehensive review of topoisomerase inhibitors as anticancer agents in the past decade
Eur. J. Med. Chem.
(2019) - et al.
From coins to cancer therapy: gold, silver and copper complexes targeting human topoisomerases
Bioorg. Med. Chem. Lett.
(2020) - et al.
DNA binding, photocleavage and topoisomerase inhibitory activity of polypyridyl ruthenium(II) complexes containing the same ancillary ligand and different main ligands
Inorg. Chim. Acta
(2013) - et al.
DNA binding, topoisomerase inhibition and cytotoxicity of palladium(II) complexes with 1,10-phenanthroline and thioureas
Inorg. Chim. Acta
(2016) - et al.
Quinoline-2-carboxaldehyde thiosemicarbazones and their Cu(II) and Ni(II) complexes as topoisomerase IIa inhibitors
J. Inorg. Biochem.
(2015) - et al.
New alicyclic thiosemicarbazone chelated zinc(II) antitumor complexes: interactions with DNA/protein, nuclease activity and inhibition of topoisomerase-I
Polyhedron
(2016) - et al.
Molecular recognition of naphthoquinone-containing compounds against human DNA topoisomerase IIα ATPase domain: a molecular modeling study
J. Mol. Liq.
(2017) - et al.
Exploring the DNA binding/cleavage, cellular accumulation and topoisomerase inhibition of 2-hydroxy-3-(aminomethyl)-1,4-naphthoquinone Mannich bases and their platinum(II) complexes
J. Inorg. Biochem.
(2013) - et al.
The first naphthosemiquinone complex of K+ with vitamin K3 analog: experiment and density functional theory
J. Mol. Struct.
(2015) - et al.
MOF with hydroxynaphthoquinone as organic linker: molecular structure of [Zn(Chlorolawsone)2(H2O)2] and thermogravimetric studies
J. Mol. Struct.
(2012)
Tautomerism and syn-anti isomerism in the p-nitrosophenol-pbenzoquinone monoxime system
Tetrahedron Lett.
Isomer trigger of hydroxyquinonemonoximes
Spectrochim. Acta A
Theoretical and experimental investigations on the structure and vibrational spectra of 2-hydroxy-3-methyl-1,4-naphthoquinone-1-oxime
J. Mol. Struc. (Theochem)
Intramolecular and intermolecular O-H-O hydrogen bond in some nickel(II) complexes with tridentate amino-oxime ligands
Inorg. Chim. Acta
Structural chemistry of transition metal complexes of oximes
Coord. Chem. Rev.
Homo- and hetero-polymetallic exchange coupled metal-oximates
Coord. Chem. Rev.
Tuning the physical properties of a metal complex by molecular techniques: the design and the synthesis of the simplest cobalt-o-dioxolene complex undergoing valence tautomerism
J. Mol. Struct.
Tautomerism in o-hydroxyanilino-1,4-naphthoquinone derivatives: structure, NMR, HPLC and Density Functional Therotic investigations
J. Mol. Struct.
Quinone chemistry and toxicity
Toxicol. Appl. Pharmacol.
Cellular roles of DNA topoisomerases: a molecular perspective
Nat. Rev. Mol. Cell Biol.
DNA topoisomerases: structure, function, and mechanism
Annu. Rev. Biochem.
Structure and function of type II DNA topoisomerases
Biochem. J.
Iron(III)-salen complexes with less DNA cleavage activity exhibit more efficient apoptosis in MCF7 cells
Org. Biomol. Chem.
Topoisomerases as anticancer targets
Biochem. J.
Topoisomerase I poisons and suppressors as anticancer drugs
Curr. Med. Chem.
Topoisomerase I and II activity in human breast, cervix, lung and colon cancer
Int. J. Cancer
Effect of oxindolimine copper(II) and zinc(II) complexes on human topoisomerase I activity
Metallomics
Role of metalation in the topoisomerase IIα inhibition and antiproliferation activity of a series of α-heterocyclic-N4-substituted thiosemicarbazones and their Cu(II) complexes
J. Med. Chem.
Structural and metal ion effects on human topoisomerase IIα inhibition by α-(N)-heterocyclic thiosemicarbazones
Chem. Res. Toxicol.
Contemporary challenges in the design of topoisomerase II inhibitors for cancer chemotherapy
Chem. Rev.
Examination of the Impact of Copper(II) α-(N)-Heterocyclic Thiosemicarbazone Complexes on DNA Topoisomerase Iiα
Chem. Res. Toxicol.
Copper(II) complexes with highly water-soluble L- and D-proline–thiosemicarbazone conjugates as potential inhibitors of topoisomerase Iiα
Inorg. Chem.
Role of metalation in the topoisomerase iiα inhibition and antiproliferation activity of a series of α-Heterocyclic-N4-substituted thiosemicarbazones and their Cu(II) complexes
J. Med. Chem.
Ruthenium(ii) polypyridyl complexes as dual inhibitors of telomerase and topoisomerase
Dalton Trans.
Cytotoxicity and preliminary mode of action studies of novel 2-aryl-4-thiopyrone-based organometallics
Dalton Trans.
Ruthenium(ii) polypyridyl complexes as dual inhibitors of telomerase and topoisomerase
Dalton Trans.
Dual inhibition of topoisomerases I and IIα by ruthenium(ii) complexes containing asymmetric tridentate ligands
Dalton Trans.
Chiral ruthenium(II) complexes with phenolic hydroxyl groups as dual poisons of topoisomerases I and Iiα
Dalton Trans.
Neutral and ionic platinum compounds containing a cyclometallated chiral primary amine: synthesis, antitumor activity, DNA interaction and topoisomerase I–cathepsin B inhibition
Dalton Trans.
Gold(III) complexes with bipyridyl ligands: solution chemistry, cytotoxicity, and DNA binding properties
J. Med. Chem.
Cited by (2)
Metal complexes of ‘Heena’ (2-hydroxy-1,4-naphthoquinone): Synthesis, Characterization and anticancer activity
2023, Inorganica Chimica ActaCitation Excerpt :The nature of EPR spectra for Mn(II) complexes; 1 and 1A, are isotropic, whereas for copper(II) complexes; 4 and 4A, are of axial symmetry. The g tensors for 4 and 4A are g‖= ∼ 2.35 and g⊥ = 2.09, since g‖>g⊥, the unpaired electron resides in the dx2-y2 orbital of Cu(II) [20,37–39]. For 1 and 3, a sharp EPR signal observed giso = ∼ 2.005, confirming the formation of naphthosemiquinone radical in these complexes.
- 1
Present address: School of Pharmacy, Shanghai Jiao Tong University, Shanghai, China.
- 2
Contributed equally.